HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Childhood Astrocytomas Treatment (PDQ®)–Patient Version

childhood brain tumor  childhood astrocytoma  anaplastic astrocytoma  anaplastic pleomorphic xanthoastrocytoma  angiocentric glioma  astroblastoma  choroid glioma of the third ventricle  diffuse astrocytoma  diffuse midline glioma  glioblastoma 

Childhood astrocytoma treatment options include surgery, observation, radiation therapy, chemotherapy, high-dose chemotherapy with stem cell transplant, and targeted therapy. Learn more about the treatment of newly diagnosed and recurrent astrocytoma in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Childhood Craniopharyngioma Treatment (PDQ®)–Patient Version

childhood brain tumor  childhood craniopharyngioma 

Childhood craniopharyngiomas are benign (not cancer) brain tumors found near the pituitary gland. Learn about the signs, tests to diagnose, and treatment (surgery, radiation therapy, chemotherapy, and immunotherapy) of pediatric craniopharyngioma in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Antineoplastons (PDQ®)–Health Professional Version

health  version  professional  antineoplastons  antineoplaston AS2-1  antineoplaston A10 

Antineoplastons are drugs composed of chemical compounds that are naturally present in the urine and blood. Antineoplastons are not approved by the U.S. Food and Drug Administration for the prevention or treatment of any disease. No randomized controlled trials showing the effectiveness of antineoplastons have been published in the peer-reviewed scientific literature. Learn more in this clinician summary.

Preview   0 Users liked this content.
NCI

Liver (Hepatocellular) Cancer Screening (PDQ®)–Patient Version

depression  suicide  disease screening  liver and intrahepatic biliary tract cancer  end-of-life treatment/management 

Liver (hepatocellular) cancer screening is not currently recommended as a routine part of cancer screening. Not all screening tests are helpful, and many have risks. Learn more about liver cancer and the tests used to detect it in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Genetics of Skin Cancer (PDQ®)–Health Professional Version

skin cancer  cancer genetics 

Genetics of Skin Cancer includes information about genes and hereditary syndromes associated with basal cell, squamous cell, and melanoma skin cancer. Get comprehensive information about the genetics of skin cancer and interventions in this summary for clinicians.

Preview   0 Users liked this content.
NCI

Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Patient Version

childhood brain tumor  thyroid cancer  childhood medulloblastoma  childhood medulloepithelioma  childhood pineoblastoma  adult thyroid cancer 

Childhood central nervous system embryonal tumors and pineal tumors are treated with surgery, radiation therapy, chemotherapy, high-dose chemotherapy with stem cell rescue and targeted therapy. Learn more in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Health Professional Version

childhood brain tumor  childhood medulloblastoma  childhood medulloepithelioma  childhood pineoblastoma 

Treatment options for children with central nervous system embryonal tumors include surgery, chemotherapy, radiation therapy, stem cell rescue, and targeted therapy. Get detailed treatment information for untreated and recurrent CNS embryonal tumors in this clinician summary.

Preview   0 Users liked this content.
NCI

Last Days of Life (PDQ®)–Health Professional Version

health  life  version  professional  days  end-of-life treatment/management 

The last days of life in cancer involves managing end-of-life (EOL) care issues for a wide range of possible symptoms and ethical dilemmas. Get detailed information about EOL issues and the role of the oncologist in this clinician summary.

Preview   0 Users liked this content.
NCI

Antineoplastons (PDQ®)–Patient Version

end-of-life treatment/management  antineoplaston AS2-1  antineoplaston A10 

Antineoplastons are derived from compounds found in urine and blood. Antineoplastons are not approved by the U.S. Food and Drug Administration for the prevention or treatment of any disease. Learn more about antineoplastons as a cancer treatment in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Gerson Therapy (PDQ®)–Health Professional Version

health  therapy  version  professional  gerson  Gerson therapy 

Gerson therapy is advocated by its supporters as a method of treating cancer patients based on changes in diet and nutrient intake. No results of laboratory or animal studies have been published in scientific journals. Get detailed information about Gerson therapy in this summary for clinicians.

Preview   0 Users liked this content.